{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:47:19Z","timestamp":1786981639644,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s11239-017-1559-0","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T20:21:35Z","timestamp":1508790095000},"page":"135-141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Heparin, coumarin, protein C, antithrombin, fibrinolysis and other clotting related resistances: old and new concepts in blood coagulation"],"prefix":"10.1007","volume":"45","author":[{"given":"A.","family":"Girolami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Girolami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"key":"1559_CR1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/bja\/88.4.467","volume":"88","author":"JA Anderson","year":"2002","unstructured":"Anderson JA, Saenko EL (2002) Heparin resistance. Br J Anaesth 88:467\u2013469","journal-title":"Br J Anaesth"},{"key":"1559_CR2","first-page":"782","volume":"25","author":"A Girolami","year":"1969","unstructured":"Girolami A, Lazzarin M, Scarpa R (1969) Studio dell\u2019antitrombina progressiva nell\u2019ipotiroidismo. Progr Med 25:782\u2013785","journal-title":"Progr Med"},{"key":"1559_CR3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1941874415591500","volume":"6","author":"AB King","year":"2016","unstructured":"King AB, O\u2019Duffy AE, Kumar AB (2016) Heparin resistance and anticoagulation failure in a challenging case of cerebral venous sinus thrombosis. Neurohospitalist 6:118\u2013121","journal-title":"Neurohospitalist"},{"key":"1559_CR4","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/MPH.0000000000000608","volume":"38","author":"L Bruwaene Van","year":"2016","unstructured":"Van Bruwaene L, Huisman A, Urbanus RT, Versluys B (2016) Heparin-resistant thrombosis due to homozygous antithrombin deficiency treated with rivaroxaban: a case report. J Pediatr Hematol Oncol 38:658\u2013660","journal-title":"J Pediatr Hematol Oncol"},{"key":"1559_CR5","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.thromres.2014.09.034","volume":"134","author":"H Zheng","year":"2014","unstructured":"Zheng H, Ma HP, Xu WF, Zhang YQ, Wu JJ, Wang J (2014) Identification of a new SERPINC1 mutation in a Kazak family that alters the heparin binding capacity of antithrombin. Thromb Res 134:1344\u20131349","journal-title":"Thromb Res"},{"key":"1559_CR6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5482\/HAMO-13-09-0047","volume":"34","author":"J Oldenburg","year":"2014","unstructured":"Oldenburg J, M\u00fcller CR, Rost S, Watzka M, Bevans CG (2014) Comparative genetics of warfarin resistance. Hamostaseologie 34:143\u2013159","journal-title":"Hamostaseologie"},{"key":"1559_CR7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cca.2013.07.010","volume":"425","author":"Y Kim","year":"2013","unstructured":"Kim Y, Smith A, Wu AH (2013) C3435T polymorphism of MDR1 gene with warfarin resistance. Clin Chim Acta 425:34\u201336","journal-title":"Clin Chim Acta"},{"key":"1559_CR8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/FPC.0000000000000184","volume":"26","author":"BC Lewis","year":"2016","unstructured":"Lewis BC, Nair PC, Heran SS, Somogyi AA, Bowden JJ, Doogue MP, Miners JO (2016) Warfarin resistance associated with genetic polymorphism of VKORC1: linking clinical response to molecular mechanism using computational modeling. Pharmacogenet Genomics 26:44\u201350","journal-title":"Pharmacogenet Genomics"},{"key":"1559_CR9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijcard.2015.04.045","volume":"188","author":"KE O\u2019Sullivan","year":"2015","unstructured":"O\u2019Sullivan KE, Meany B, Hurley JP (2015) Warfarin resistance due to VKORC1 gene mutation in a patient following mechanical aortic valve replacement with an ON-X valve. Int J Cardiol 188:63\u201364","journal-title":"Int J Cardiol"},{"key":"1559_CR10","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","volume":"90","author":"B Dahlb\u00e4ck","year":"1993","unstructured":"Dahlb\u00e4ck B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004\u20131008","journal-title":"Proc Natl Acad Sci USA"},{"key":"1559_CR11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","volume":"369","author":"RM Bertina","year":"1994","unstructured":"Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64\u201367","journal-title":"Nature"},{"key":"1559_CR12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0268-960X(98)90029-7","volume":"12","author":"A Girolami","year":"1998","unstructured":"Girolami A, Simioni P, Scarano L, Girolami B, Marchiori A (1998) Hemorrhagic and thrombotic disorders due to factor V deficiencies and abnormalities: an updated classification. Blood Rev 12:45\u201351","journal-title":"Blood Rev"},{"key":"1559_CR13","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1182\/blood.V91.4.1135","volume":"91","author":"WP Chan","year":"1998","unstructured":"Chan WP, Lee CK, Kwong YL, Lam CK, Liang R (1998) A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Blood 91:1135\u20131139","journal-title":"Blood"},{"key":"1559_CR14","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood.V91.4.1140","volume":"91","author":"D Williamson","year":"1998","unstructured":"Williamson D, Brown K, Luddington R, Baglin C, Baglin T. Factor V (1998) Cambridge: a new mutation (Arg306\u00ef\u2192Thr) associated with resistance to activated protein C. Blood 91:1140\u20131144","journal-title":"Blood"},{"key":"1559_CR15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1365-2141.2003.04624.x","volume":"123","author":"AD Mumford","year":"2003","unstructured":"Mumford AD, McVey JH, Morse CV, Gomez K, Steen M, Norstrom EA, Tuddenham EG, Dahlback B, Bolton-Maggs PH (2003) Factor V I359T: a novel mutation associated with thrombosis and resistance to activated protein C. Br J Haematol 123:496\u2013501","journal-title":"Br J Haematol"},{"key":"1559_CR16","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1182\/blood.V85.12.3518.bloodjournal85123518","volume":"85","author":"B Z\u00f6ller","year":"1995","unstructured":"Z\u00f6ller B, Berntsdotter A, Garc\u00eda de Frutos P, Dahlb\u00e4ck B (1995) Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 85:3518\u20133523","journal-title":"Blood"},{"key":"1559_CR17","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2141.2012.09134.x","volume":"157","author":"PV Jenkins","year":"2012","unstructured":"Jenkins PV, Rawley O, Smith OP, O\u2019Donnell JS (2012) Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol 157:653\u2013663","journal-title":"Br J Haematol"},{"key":"1559_CR18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.thromres.2006.08.014","volume":"120","author":"HA Tran","year":"2007","unstructured":"Tran HA, Anand SS, Hankey GJ, Eikelboom JW (2007) Aspirin resistance. Thromb Res 120:337\u2013346","journal-title":"Thromb Res"},{"key":"1559_CR19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejogrb.2016.12.023","volume":"210","author":"CNH Abheiden","year":"2017","unstructured":"Abheiden CNH, Fuijkschot WW, Ardu\u00e7 A, van Diemen JJK, Harmsze AM, de Boer MA, Thijs A, de Vries JIP (2017) Post-pregnancy aspirin resistance appears not to be related with recurrent hypertensive disorders of pregnancy. Eur J Obstet Gynecol Reprod Biol 210:139\u2013143","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1559_CR20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/138161206775193064","volume":"12","author":"L Macchi","year":"2006","unstructured":"Macchi L, Sorel N, Christiaens L (2006) Aspirin resistance: definitions, mechanisms, prevalence, and clinical significance. Curr Pharm Des 12:251\u2013258","journal-title":"Curr Pharm Des"},{"issue":"6","key":"1559_CR21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.5414\/CP202637","volume":"55","author":"R Eskandarian","year":"2017","unstructured":"Eskandarian R, Razavi M, Fattah A, Ghods K, Forozeshfard M (2017) Prevalence of aspirin resistance in patients with type II diabetes: a descriptive-analytical study. Int J Clin Pharmacol Ther 55(6):493\u2013497","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1559_CR22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.moh.0000239704.17427.9b","volume":"13","author":"F Violi","year":"2006","unstructured":"Violi F, Pignatelli P (2006) Aspirin resistance: is this term meaningful? Curr Opin Hematol 13:331\u2013336","journal-title":"Curr Opin Hematol"},{"key":"1559_CR23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2169\/internalmedicine.45.1438","volume":"45","author":"S Fuchigami","year":"2006","unstructured":"Fuchigami S, Oshima S, Hokimoto S, Noda K, Fukushima H, Yoshida T, Takushi Y, Ogawa H (2006) Subacute thrombosis after coronary stenting occurring with resistance to ticlopidine. Intern Med 45:675\u2013678","journal-title":"Intern Med"},{"key":"1559_CR24","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","volume":"109","author":"S Matetzky","year":"2004","unstructured":"Matetzky S, Shenkman B, Guetta V, Shechter M, Beinart R, Goldenberg I, Novikov I, Pres H, Savion N, Varon D, Hod H (2004) Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 109:3171\u20133175","journal-title":"Circulation"},{"key":"1559_CR25","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jacc.2005.01.034","volume":"45","author":"TA Nguyen","year":"2005","unstructured":"Nguyen TA, Diodati JG, Pharand C (2005) Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol 45:1157\u20131164","journal-title":"J Am Coll Cardiol"},{"key":"1559_CR26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00001721-199810000-00001","volume":"9","author":"A Girolami","year":"1998","unstructured":"Girolami A, Scarano L, Saggiorato G, Girolami B, Bertomoro A, Marchiori A (1998) Congenital deficiencies and abnormalities of prothrombin. Blood Coagul Fibrinolysis 9:557\u2013569","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1559_CR27","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1055\/s-0033-1348948","volume":"39","author":"S Lancellotti","year":"2013","unstructured":"Lancellotti S, Basso M, De Cristofaro R (2013) Congenital prothrombin deficiency: an update. Semin Thromb Hemost 39:596\u2013606","journal-title":"Semin Thromb Hemost"},{"key":"1559_CR28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11239-009-0342-2","volume":"29","author":"A Girolami","year":"2010","unstructured":"Girolami A, Candeo N, Vettore S, Lombardi AM, Girolami B (2010) The clinical significance of the lack of arterial or venous thrombosis in patients with congenital prothrombin or FX deficiency. J Thromb Thrombolysis 29:299\u2013302","journal-title":"J Thromb Thrombolysis"},{"key":"1559_CR29","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1056\/NEJMoa1201994","volume":"366","author":"Y Miyawaki","year":"2012","unstructured":"Miyawaki Y, Suzuki A, Fujita J, Maki A, Okuyama E, Murata M, Takagi A, Murate T, Kunishima S, Sakai M, Okamoto K, Matsushita T, Naoe T, Saito H, Kojima T (2012) Thrombosis from a prothrombin mutation conveying antithrombin resistance. N Engl J Med 366:2390\u20132396","journal-title":"N Engl J Med"},{"key":"1559_CR30","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1111\/jth.12367","volume":"11","author":"V Djordjevic","year":"2013","unstructured":"Djordjevic V, Kovac M, Miljic P, Murata M, Takagi A, Pruner I, Francuski D, Kojima T, Radojkovic D (2013) A novel prothrombin mutation in two families with prominent thrombophilia\u2013the first cases of antithrombin resistance in a Caucasian population. J Thromb Haemost 11:1936\u20131939","journal-title":"J Thromb Haemost"},{"key":"1559_CR31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bcmd.2012.11.008","volume":"50","author":"S Sivasundar","year":"2013","unstructured":"Sivasundar S, Oommen AT, Prakash O, Baskaran S, Biswas R, Nair S, Mohan CG, Biswas L (2013) Molecular defect of \u2018Prothrombin Amrita\u2019: substitution of arginine by glutamine (Arg553 to Gln) near the Na(+) binding loop of prothrombin. Blood Cells Mol Dis 50:182\u2013183","journal-title":"Blood Cells Mol Dis"},{"key":"1559_CR32","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/ATVBAHA.115.306914","volume":"36","author":"C Bulato","year":"2016","unstructured":"Bulato C, Radu CM, Campello E, Gavasso S, Spiezia L, Tormene D, Simioni P (2016) New prothrombin mutation (Arg596Trp, Prothrombin Padua 2) associated With venous thromboembolism. Arterioscler Thromb Vasc Biol 36:1022\u20131029","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1559_CR33","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1172\/JCI69091","volume":"123","author":"LM Vincent","year":"2013","unstructured":"Vincent LM, Tran S, Livaja R, Bensend TA, Milewicz DM, Dahlb\u00e4ck B (2013) Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPI\u03b1. J Clin Invest 123:3777\u20133787","journal-title":"J Clin Invest"},{"key":"1559_CR34","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1182\/blood-2014-08-592733","volume":"125","author":"ML Cunha","year":"2015","unstructured":"Cunha ML, Bakhtiari K, Peter J, Marquart JA, Meijers JC, Middeldorp S (2015) A novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function. Blood 125:1822\u20131825","journal-title":"Blood"},{"key":"1559_CR35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.thromres.2012.07.025","volume":"130","author":"B Tardy-Poncet","year":"2012","unstructured":"Tardy-Poncet B, Piot M, Brunet D, Chapelle C, Bonardel M, Mismetti P, Morange P, Tardy B (2012) TFPI resistance related to inherited or acquired protein S deficiency. Thromb Res 130:925\u2013928","journal-title":"Thromb Res"},{"key":"1559_CR36","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/ene.12369","volume":"21","author":"D Faille","year":"2014","unstructured":"Faille D, Labreuche J, Meseguer E, Huisse MG, Ajzenberg N, Mazighi M (2014) Endothelial markers are associated with thrombolysis resistance in acute stroke patients. Eur J Neurol 21:643\u2013647","journal-title":"Eur J Neurol"},{"key":"1559_CR37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.thromres.2015.12.023","volume":"138","author":"F Semeraro","year":"2016","unstructured":"Semeraro F, Incampo F, Ammollo CT, Dellanoce C, Paoletti O, Testa S, Colucci M (2016) Dabigatran but not rivaroxaban or apixaban treatment decreases fibrinolytic resistance in patients with atrial fibrillation. Thromb Res 138:22\u201329","journal-title":"Thromb Res"},{"key":"1559_CR38","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1055\/s-0037-1614953","volume":"79","author":"RR Hantgan","year":"1998","unstructured":"Hantgan RR, Jerome WG, Handt S (1998) Platelets and endothelial cells act in concert to delay thrombolysis\u2013evidence from an in vitro model of the human occlusive thrombus. Thromb Haemost 79:602\u2013608","journal-title":"Thromb Haemost"},{"issue":"3 Suppl","key":"1559_CR39","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1378\/chest.124.3_suppl.26S","volume":"124","author":"CT Esmon","year":"2003","unstructured":"Esmon CT (2003) The protein C pathway. Chest 124(3 Suppl):26S\u201332S","journal-title":"Chest"},{"key":"1559_CR40","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/liv.13087","volume":"36","author":"V Mura La","year":"2016","unstructured":"La Mura V, Tripodi A, Tosetti G, Cavallaro F, Chantarangkul V, Colombo M, Primignani M (2016) Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis. Liver Int 36:1322\u20131330","journal-title":"Liver Int"},{"key":"1559_CR41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jns.2014.08.038","volume":"346","author":"J Sargento-Freitas","year":"2014","unstructured":"Sargento-Freitas J, Silva F, Pego J, Duque C, Cordeiro G, Cunha L (2014) Cardioembolic stroke in a patient taking Dabigatran Etexilate: the first case report of clinical and pharmacologic resistance. J Neurol Sci 346:348\u2013349","journal-title":"J Neurol Sci"},{"key":"1559_CR42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.hlc.2011.08.014","volume":"21","author":"RA Stewart","year":"2012","unstructured":"Stewart RA, Astell H, Young L, White HD (2012) Thrombosis on a mechanical aortic valve whilst anti-coagulated with dabigatran. Heart Lung Circ 21:53\u201355","journal-title":"Heart Lung Circ"},{"key":"1559_CR43","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa0904377","volume":"361","author":"P Simioni","year":"2009","unstructured":"Simioni P, Tormene D, Tognin G, Gavasso S, Bulato C, Iacobelli NP, Finn JD, Spiezia L, Radu C, Arruda VR (2009) X-linked thrombophilia with a mutant factor IX (factor IX Padua). N Engl J Med 361:1671\u20131675","journal-title":"N Engl J Med"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-017-1559-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-017-1559-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-017-1559-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T23:25:11Z","timestamp":1659655511000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-017-1559-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["1559"],"URL":"https:\/\/doi.org\/10.1007\/s11239-017-1559-0","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]}}}